Dogwood Therapeutics, Inc. (DWTX) Current Reports & Earnings Releases
Upcoming
- 2026-11-05 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-17 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-26 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-18 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-12 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-01-20 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-13 | 8-K | Material Agreement, Termination of Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-28 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2025-11-21 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-09-29 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-02 | 8-K | Officer / Director Changes | SEC |
| 2025-06-24 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-14 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-12 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-21 | 8-K | Listing Notice | SEC |
| 2024-11-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-10-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-07 | 8-K | Material Agreement, Acquisition or Disposition, Unregistered Sales, Item 3.03, Officer / Director Changes, Charter Amendments, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-08 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-20 | 8-K | Shareholder Vote Results | SEC |
| 2024-06-12 | 8-K | Listing Notice | SEC |
| 2024-05-20 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-05-07 | 8-K | Listing Notice | SEC |
| 2024-03-06 | 8-K | Shareholder Vote Results | SEC |
| 2024-02-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-02-27 | 8-K | Officer / Director Changes | SEC |
| 2024-01-03 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.